Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT01792050

Public ClinicalTrials.gov record NCT01792050. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effects, good and/or bad, of standard of care therapy (docetaxel or paclitaxel) with or without the addition of 1-Methyl-D-tryptophan (referred to as indoximod) an experimental drug to find out which treatment is better.

Study identification

NCT ID
NCT01792050
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NewLink Genetics Corporation
Industry
Enrollment
169 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2013 (Type not available)
Primary completion
Jul 1, 2016 (Actual)
Completion
Jul 7, 2017 (Actual)
Last update posted
May 28, 2020

2013 – 2017

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
27
Facility City State ZIP Site status
University of Florida Health Cancer Center Gainesville Florida 32610 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
Space Coast Cancer Center Titusville Florida 32796 —
Cleveland Clinic - Florida Weston Florida 33331 —
University Cancer & Blood Center, LLC Athens Georgia 30607 —
Georgia Regents University Augusta Georgia 30912 —
Illinois Cancer Specialists Arlington Heights Illinois 60005 —
University of Illinois Cancer Center Chicago Illinois 60612 —
Indiana University Health Goshen Center for Cancer Care Goshen Indiana 45626 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Eastchester Center for Cancer Care The Bronx New York 10469 —
University of North Carolina Chapel Hill North Carolina 27599 —
Wake Forest Baptist Hospital Winston-Salem North Carolina 27157 —
Fairview Hospital Cleveland Ohio 44111 —
Cleveland Clinic - Taussig Cancer Center Cleveland Ohio 44195 —
Taussig Cancer Institute Mayfield Heights Ohio 44124 —
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010 —
Pennsylvania State University Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Paoli Hospital Paoli Pennsylvania 19301 —
Lankenau Medical Center Wynnewood Pennsylvania 19096 —
University of Tennessee Medical Center Knoxville Tennessee 37920 —
MD Anderson Cancer Center Houston Texas 77303 —
University of Virginia Charlottesville Virginia 22908 —
Lynchburg Hematology Oncology Lynchburg Virginia 24501 —
Peninsula Cancer Center Newport News Virginia 23601 —
Virginia Commonwealth University Richmond Virginia 23298 —
Wheaton Franciscan Healthcare- Reiman Cancer Center Franklin Wisconsin 53132 —
Aurora Baycare Green Bay Wisconsin 54311 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01792050, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01792050 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →